Investing

Investment analysis, share recommendations, and market insights.

Premium

4 CAR T-cell researchers

One of the most exciting areas in medicine is the emerging field of CAR-T cell therapy, a potentially revolutionary treatment in cancer and a range of other serious diseases. As a world-class centre of medical research, Australia is at the forefront of this area. Here are four ASX-listed companies involved in this fascinating area.

James Dunn · August 11, 2025
Premium

Could AI disrupt REA’s pot of gold?

Last week, property portal REA Group (REA) reported one of those sensational financial results. But could REA be vulnerable to new disruptive business models driven by AI. Let’s explore this, plus insights from the brokers and the company’s outlook.

Paul Rickard · August 11, 2025
Premium

How to let Trump-created volatility work for you

All this market fear and irrational selling creates buying opportunities in copper equities. The good news is higher short-term market volatility will create more opportunities to buy irrationally oversold assets. Here’s an ETF I like.

Tony Featherstone · August 7, 2025
Premium

‘HOT’ stock: Aristocrat Leisure (ALL)

In our “HOT” stock article today, Michael Gable, Managing Director of Fairmont Equities, gives more details on his rev elation that the chart is indicating that now’s a good time to buy Aristocrat Leisure (ALL).

Maureen Jordan · August 7, 2025
Premium

‘HOT’ stock: ResMed (RMD)

In our “HOT” stock column today, Head of Asian Desk at Morgans Financial Limited, Raymond Chan, explains why Morgans maintains its ADD rating for ResMed (RMD).

Maureen Jordan · August 4, 2025
Premium

Short term nerves, long-term confidence on stocks

Major errors in US statistics for the number of jobs created is a new curve ball bound to be another challenge for stock markets. I’ve been holding back my own cash and that of my financial planning clients. Now I’m going to wait and see how this recession talk plays out. While my playbook for investing short term is to watch the market reaction this week, what’s my long-term play?

Peter Switzer · August 4, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.